Page 36 - Vaccine

Steep death graph, no peak yet: Why India is behind the curve on Covid-19

While the mortality rate seems to be plateauing in UK , Spain and Italy after peaking, in India he bad news is that it hasn't reached the high point after which it can start tapering off

India simplifies clinical trial rules for Covid-19 vaccine manufacturing

Govt will take inter-departmental approach to ensure right vaccine candidate is available for Indians at the earliest

CEPI to grant $14 mn for trial of Bharat Biotech's Chikungunya vaccine

The vaccine completed standard pre-clinical studies, and an optimum immune response was elicited by the adjuvant vaccine in phase-1 trials in India

Covid-19 vaccine development moving positively, says Bharat Biotech CEO

He expressed satisfaction on the progress of the research connected with the vaccine development so far, but insisted that "in science, things can change"

Gilead's remdesivir shows modest improvement in moderate Covid-19 patients

At day 11, around 76% of the patients in the 5-day treatment group showed improvement in clinical status versus 66% for standard care alone, Gilead said

WHO, 37 countries launch alliance to share tools to battle Covid-19

The WHO issued a "Solidarity Call to Action", asking other stakeholders to join the voluntary push.

Vaccine for Covid-19 will take long time to be ready: Kiran Mazumdar-Shaw

The quickest for any vaccine to be prepared is not less than four years, says Kiran Mazumdar-Shaw.

Sun Pharma to test two drugs for treatment of Covid-19, stock up 3.5%

At present there are three clinical trials underway to test nafamostat in Covid19 patients around the world

30 groups in India working on coronavirus vaccine, 20 at 'good pace'

ICMR conducting study on presence of antibodies in people, results next week

GSK to produce 1 billion doses of coronavirus vaccine booster in 2021

The British drugmaker is working on its own COVID vaccine with Sanofi

Oxford University Covid-19 vaccine trial has 50% chance of 'no result'

The University of Oxford last week announced that the advance human trial of the vaccine will involve up to 10,260 volunteers across the UK

4 Covid-19 vaccines may soon enter the clinical-trial stage: Harsh Vardhan

There are over 100 candidate vaccines which are at different levels of development

Polio and measles could surge after disruption of vaccine programs

The problem of slipping vaccine rates is not limited to developing countries

Record jump in Covid-19 cases as tally crosses 125,000; 1st case in Sikkim

Active cases rose to 69,597, while 51,783 people have recovered and a patient has migrated, according to the ministry bulletin

Coronavirus Vaccine Shows Promising Early Results in China

The early-stage trial, published in the Lancet, was conducted by researchers at several laboratories and included 108 participants aged 18 to 60

US plans massive Covid-19 vaccine testing effort to meet year-end deadline

To get there, leading vaccine makers have agreed to share data and lend the use of their clinical trial networks to competitors should their own candidate fail, the scientists said

First Covid-19 vaccine to reach phase-1 trial is safe, say researchers

Several teams across the world are in a race to develop a vaccine for coronavirus infection

Oxford University's Covid-19 vaccine moves to next stage of human trials

The first phase of the trial began last month with 1,000 healthy adults aged 55 and under as volunteers.

US secures 300 million doses of potential AstraZeneca Covid-19 vaccine

Vaccines are seen by world leaders as the only real way to restart their stalled economies.

Oxford University's candidate for coronavirus vaccine fails animal tests

The vaccine's failure to prevent the virus from attacking the rhesus macaque is a setback and kills the hope of treating humans